Bromodomain Degraders
| Cat. No. | Product Name / Activity |
|---|---|
| 7256 | ARV 771 |
| Potent BET bromodomain PROTAC®; also degrades BRD-tagged chimeric antigen receptors (CAR) in T cells | |
| 6356 | AT 1 |
| (+)-JQ1 based PROTAC® with selectivity for BRD4 | |
| 7319 | BRD PHOTAC-I-3 |
| Photoswitchable BET bromodomain degrader (PHOTAC) | |
| 7433 | cis-SIM1 |
| Negative control for SIM1 (Cat. No. 7432) | |
| 6327 | dBET1 |
| (+)-JQ1 based Degrader targeting BET bromodomains, active in vivo | |
| 6945 | dBET6 |
| Potent and selective (+)-JQ1 based Degrader targeting BET bromodomains, active in vivo | |
| 6606 | dBRD9 |
| Potent and selective BRD9 Degrader | |
| 6943 | dBRD9-A |
| Potent BRD9 Degrader | |
| 6154 | MZ 1 |
| BRD4 Degrader; preferentially degrades BRD4 over BRD2/3 | |
| 6936 | VZ 185 |
| Potent and selective BRD7/9 Degrader |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDFStem Cell Research Product Guide
Our guide highlights the use of small molecules in stem cell research and cell therapy and lists relevant products.
Request copyRequest PDFEpigenetics Scientific Review
Our Epigenetics review gives an overview of the development of chemical probes for epigenetic targets, and discusses their biological effects.
Request copyRequest PDFEpigenetics in Cancer Life Science Poster
Taken from the Cancer Product Guide Edition 3
Our Epigenetics in Cancer poster summarizes the main epigenetic targets in cancer, and highlights chemical compounds for the inhibition of these targets.
Request copyDownload PDFRheumatoid Arthritis Life Science Poster
Written by Adam P. Cribbs et al.
Our Rheumatoid Arthritis poster summarizes the disease pathology and highlights some of the epigenetic modifications associated with the condition.
Request copyDownload PDF